Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt · Delayed Price · Currency is EGP

317.80

+6.80 (2.19%)

At close: Aug 5, 2026

EGX:MPCI Financials Overview

Financials in millions EGP. Fiscal year is July - June.

Millions EGP. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	1,675	1,508	871.91	663.83	551.26	518.11
Revenue Growth	36.21%	72.93%	31.34%	20.42%	6.40%	6.08%
Gross Profit	685.08	679.98	300.29	212.95	149.39	164.98
Operating Income	528.06	522.35	211.41	95.89	69.04	34.13
Net Income	518.98	505.28	191.46	90.44	74.09	41.81
Earnings Per Share	22.81	22.21	34.04	16.08	13.17	-
EPS Growth	-65.93%	-34.75%	111.70%	22.07%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	424.65	678.63	519.86	143.53	83.83	52.6
Total Debt	83.98	94.94	177.04	13.32	4.73	5.36
Net Cash (Debt)	340.66	583.69	342.81	130.21	79.1	47.23
Net Cash Growth	-22.34%	70.27%	163.29%	64.62%	67.45%	20.02%
Net Cash Per Share	14.97	25.66	60.94	23.15	14.06	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	-78.45	86.89	183.2	57.94	36.47	3.47
Capital Expenditures	-24.68	-21.23	-24.37	-11.45	-12.92	-2.07
Free Cash Flow	-103.13	65.65	158.83	46.49	23.55	1.4
Free Cash Flow Growth	-	-58.66%	241.64%	97.45%	1578.00%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	40.89%	45.10%	34.44%	32.08%	27.10%	31.84%
Operating Margin	31.52%	34.64%	24.25%	14.45%	12.52%	6.59%
Pretax Margin	40.02%	43.26%	26.32%	16.57%	14.21%	8.04%
Profit Margin	30.98%	33.51%	21.96%	13.62%	13.44%	8.07%
FCF Margin	-6.16%	4.35%	18.22%	7.00%	4.27%	0.27%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 5, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Dividend Per Share	13.187	13.187	4.000	2.000
Dividend Per Share Growth	229.68%	229.67%	100.00%	-
Dividend Yield	4.24%	18.93%	15.24%	22.94%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PE Ratio	13.63	3.33	2.64	1.93	1.05	3.59
P/FCF Ratio	-	25.65	3.18	3.75	3.31	107.03
PS Ratio	4.22	1.12	0.58	0.26	0.14	0.29